Nuventra

Nuventra was a U.S.-based clinical pharmacology consulting company serving biopharmaceutical sponsors and CROs rather than a therapeutic drug developer with its own pipeline. The company specialized in strategic drug development support, including clinical pharmacology consulting, pharmacokinetics, pharmacodynamics, pharmacometrics, population PK, and biosimulation. Founded in 2008 and headquartered in Durham, North Carolina, it built a reputation for helping clients design, interpret, and de-risk development programs across multiple therapeutic areas. In May 2021, Nuventra was acquired by CATO SMS, which later became Allucent, and its capabilities were integrated into the acquirer's broader drug development services platform.